Anticonvulsant drug or neuromodulator? The growing case for anticonvulsant uses beyond epilepsy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Neuroscience
Link
http://link.springer.com/content/pdf/10.1007/s11910-004-0056-y.pdf
Reference10 articles.
1. Storey JR, Calder CS, Hart DE, Potter DL: Topiramate in migraine prevention: a double-blind, placebo-controlled trial. Headache 2001, 41:968–975. Well-designed trial supporting the effectiveness of topiramate in migraine.
2. Mathew NT, Rapoport A, Saper J, et al.: Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119–128.
3. Klapper J, on behalf of the Divalproex Sodium in Migraine Prophyllaxis Study Group: Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalgia 1997, 17:103–108.
4. Spira PJ, Beran RG, for the Australian Gabapentin Chronic Headache Group: Gabapentin in the prophylaxis of chronic daily headache. Neurology 2003, 61:1753–1759. Well-designed trial supporting the effectiveness of gabapentin in chronic daily headache.
5. Bowden CL, Calabrese JR, Sachs G, et al., for the Lamictal 606 Study Group: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003, 60:392–400. Well-designed trial supporting the effectiveness of lamotrigine in bipolar disorder.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Review: A review of the use of zonisamide in Parkinson’s disease;Therapeutic Advances in Neurological Disorders;2009-08-12
2. Fármacos antiepilépticos en la enfermedad de Parkinson;Medicina Clínica;2008-10
3. Zonisamida en el temblor esencial refractario;Revista de Neurología;2008
4. Nuevos fármacos antiepilépticos y dolor neuropático. De la medicina molecular a la clínica;Medicina Clínica;2007-10
5. Tratamiento del temblor esencial;Medicina Clínica;2007-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3